Filing Details

Accession Number:
0001237648-22-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-27 12:45:04
Reporting Period:
2022-12-22
Accepted Time:
2022-12-27 12:45:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA In Vitro & In Vivo Diagnostic Substances (2835) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1570492 S. Kevin Wilson 3760 Rocky Mountain Avenue
Loveland CO 80538
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-22 2,299 $59.65 154,913 No 4 P Direct
Common Stock Acquisiton 2022-12-22 105 $59.64 155,018 No 4 P Direct
Common Stock Acquisiton 2022-12-22 796 $59.62 155,814 No 4 P Direct
Common Stock Acquisiton 2022-12-22 240 $59.57 156,054 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 162,763 Indirect by Cuattro, LLC
Common Stock 9,000 Indirect by Spouse
Common Stock 138,743 Indirect by Wilson Family Tr.
Footnotes
  1. The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 1, 2022.